Brukinsa (zanubrutinib)

pCPA File Number: 22458
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic lymphocytic leukemia (CLL) in adult patients
Sponsor/Manufacturer:
BeiGene, Ltd.
CDA-AMC Project Number:
PC0310-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: